Comparison of the Effects of Desflurane-Remifentanyl and Propofol-Remifentanyl Anesthesia on Intraoperative Cerebral Oxygenation in Patients Undergoing Laparoscopic Cholecystectomy

April 1, 2026 updated by: Hilal GUNAL SAZAK, Ankara Ataturk Sanatorium Training and Research Hospital

Comparison of the Effects of Desflurane-Remifentanyl and Propofol-Remifentanyl Anesthesia on Intraoperative Cerebral Oxygenation and Postoperative Complications in Patients Undergoing Laparoscopic Cholecystectomy

Study Population:

Patients undergoing elective laparoscopic cholecystectomy under general anesthesia will be included.

Study Design:

This is an observational study. No interventions outside routine clinical practice will be applied. All procedures will be performed by experienced anesthesiologists according to standard institutional protocols.

Data Collection

Preoperative Data:

The following variables will be recorded from anesthesia charts:

Demographics: age, sex, height, weight, body mass index (BMI) Education level Smoking, alcohol, and substance use status Routine preoperative laboratory tests

Clinical scores:

Charlson Comorbidity Index (CCI) Beck Anxiety Scale ARISCAT Score STOP-BANG Score Montreal Cognitive Assessment (MoCA) ASA Physical Status Classification

Intraoperative Data:

Patients will be observed in two groups based on anesthesia technique:

Desflurane + remifentanyl Total intravenous anesthesia (TIVA: propofol + remifentanyl)

The following parameters will be recorded:

Hemodynamic data: blood pressure, heart rate Oxygenation parameters: SpO₂, SpO₂/FiO₂ ratio Cerebral and depth monitoring: NIRS, BIS Respiratory mechanics Oxygen Saturation Index (OSI = [Pmean × FiO₂] / SpO₂) Mechanical ventilator parameters

Time Points for Measurement:

Before induction After induction After intubation Every 20 minutes intraoperatively After extubation

Additional Intraoperative Variables:

Duration of surgery and anesthesia

Total anesthetic drug consumption:

Desflurane and remifentanyl Propofol and remifentanyl (TIVA group) Intraoperative blood transfusion (yes/no) Total blood loss Urine output Recovery time Postoperative Follow-up ICU admission (planned or unplanned)

Pain assessment using Numeric Rating Scale (NRS):

PACU Postoperative 1st, 3rd, 6th, 12th, and 24th hours

Postoperative Complications:

Nausea and vomiting Hypotension Arrhythmia (bradycardia, tachycardia) Pulmonary edema Atelectasis Pneumonia Pneumothorax Pleural effusion Cognitive dysfunction

Other Outcomes:

Postoperative MoCA and Beck Anxiety Scale scores Length of hospital stay Length of ICU stay (if applicable) Mortality during follow-up

Study Overview

Detailed Description

This observational study aims to investigate the relationship between intraoperative cerebral oxygenation and systemic oxygenation parameters in patients undergoing elective laparoscopic cholecystectomy under general anesthesia.

Cerebral oxygenation monitoring using near-infrared spectroscopy (NIRS) has become increasingly important in perioperative care, as it provides real-time, non-invasive information about cerebral perfusion and oxygen balance. However, the relationship between cerebral oxygenation and routinely monitored systemic oxygenation parameters remains unclear. This study is designed to evaluate these associations under standardized clinical conditions.

After obtaining ethics committee approval, patients scheduled for elective laparoscopic cholecystectomy will be prospectively enrolled. All procedures will be conducted according to routine clinical practice without any additional intervention. Anesthesia management will be performed by experienced anesthesiologists following institutional protocols.

Patients will be observed according to the anesthesia technique applied: desflurane-remifentanyl anesthesia or total intravenous anesthesia (TIVA) with propofol-remifentanyl. Intraoperative monitoring will include standard hemodynamic parameters, peripheral oxygen saturation (SpO₂), cerebral oxygenation (NIRS), bispectral index (BIS), respiratory mechanics, and derived indices such as the SpO₂/FiO₂ ratio and oxygen saturation index (OSI).

Measurements will be recorded at predefined time points, including before and after induction, after intubation, after positioning, at 20-minute intervals during surgery, and after extubation. Additional intraoperative data such as anesthetic drug consumption, duration of surgery and anesthesia, blood loss, transfusion requirements, urine output, and recovery time will also be documented.

Postoperative outcomes will include pain scores assessed by the Numeric Rating Scale (NRS) at multiple time points, intensive care unit (ICU) admission, and postoperative complications such as nausea, vomiting, hemodynamic instability, respiratory complications, and cognitive dysfunction. Cognitive and anxiety assessments will be performed using the Montreal Cognitive Assessment (MoCA) and Beck Anxiety Scale. Length of hospital stay, ICU stay, and mortality will also be recorded.

The findings of this study are expected to contribute to a better understanding of the relationship between cerebral and systemic oxygenation and may help optimize intraoperative monitoring strategies in routine anesthesia practice.

Study Type

Observational

Enrollment (Estimated)

84

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Ankara
      • Ankara, Ankara, Turkey (Türkiye), 06010
        • ANKARA ATATURK SANATORİUM TRAİNİNG AND RESEARCH HOSPITAL
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Adult patients undergoing elective surgery under general anesthesia, receiving either desflurane - remifentanyl or propofol- remifentanyl anesthesia

Description

Inclusion Criteria:

  • Those with ASA 1-2-3
  • Those who have undergone laparoscopic cholecystectomy
  • Those with BMI between 18-40 kg/m2

Exclusion Criteria:

  • Emergency surgeries
  • Individuals with neurological disorders, diseases, or drug (opioid or sedative) use that affect cognitive function
  • Individuals who do not speak Turkish
  • Individuals who have received general anesthesia within the last 7 days
  • Individuals with severe organ dysfunction
  • Individuals allergic to the drugs used in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Desflurane+Remifentanyl Group
Desflurane+Remifentanyl Group: Patients who receive remifentanil and desflurane during anesthesia
Propofol + Remifentanyl Group
Propofol + Remifentanyl Group: Patients who receive remifentanyl and propofol during anesthesia

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative cerebral oxygenation
Time Frame: During surgery
Intraoperative cerebral oxygenation in patients receiving desflurane-remifentanyl or propofol-remifentanyl anesthesia
During surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative SpO2 Values
Time Frame: During Surgery (per 20 minutes)
Intraoperative SpO2 values will be recorded every 20 minutes
During Surgery (per 20 minutes)
Intraoperative Heart Rate Values
Time Frame: During surgery (Per 20 minutes)
Intraoperative heart rate values will be recorded every 20 minutes
During surgery (Per 20 minutes)
Intraoperative TV-Tidal Volume Values
Time Frame: During surgery (Per 20 minutes)
Intraoperative TV-Tidal Volume values will be recorded every 20 minutes
During surgery (Per 20 minutes)
Anesthetic complications
Time Frame: From end of surgery until hospital discharge
Postoperative anesthetic complications
From end of surgery until hospital discharge
Correlation between systemic oxygenation and cerebral oxygenation
Time Frame: During surgery (per 20 minutes)
Correlation of intraoperative cerebral oxygenation with systemic oxygenation parameters
During surgery (per 20 minutes)
Intraoperative SpO2/FiO2 Values
Time Frame: During Surgery (per 20 minutes)
Intraoperative SpO2/FiO2 values will be recorded every 20 minutes
During Surgery (per 20 minutes)
Intraoperative Oxygen Saturation Index- OSI Values
Time Frame: During Surgery (per 20 minutes)
The Oxygen Saturation Index- OSI values will be recorded every 20 minutes
During Surgery (per 20 minutes)
Intraoperative Blood Pressure Values
Time Frame: During Surgery ( Per 20 minutes)
Intraoperative blood pressure values will be recorded every 20 minutes
During Surgery ( Per 20 minutes)
Intraoperative PIP- Peak Inspiratory Pressure Values
Time Frame: During Surgery ( Per 20 minutes)
Intraoperative PIP- Peak Inspiratory Pressure values will be recorded every 20 minutes
During Surgery ( Per 20 minutes)
Intraoperative Pplat-Plateau Pressure Values
Time Frame: During Surgery (Per 20 minutes)
Intraoperative Pplat-Plateau Pressure values will be recorded every 20 minutes
During Surgery (Per 20 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hilal Sazak, Prof. Dr, ANKARA ATATURK SANATORİUM TRAİNİNG AND RESEARCH HOSPITAL

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 6, 2026

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

March 26, 2026

First Submitted That Met QC Criteria

April 1, 2026

First Posted (Actual)

April 8, 2026

Study Record Updates

Last Update Posted (Actual)

April 8, 2026

Last Update Submitted That Met QC Criteria

April 1, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on ıntraoperative Cerebral Oxygenation

Subscribe